BridgeBio Pharma (BBIO) stock — price, news and analysis
BridgeBio Pharma (BBIO) trades on US markets (NASDAQ / NYSE). Track its live price and interactive chart below; the latest BBIO news will be collected here as it is published.
Catalystsby D-day
FOMC = U.S. Fed official schedule · expiry = US options/futures (3rd Friday)
Latest US market news
No BBIO-specific stories yet — here's what's moving the US market. All US news ›
Eli Lilly, Regeneron Among First Seven in FDA's Manufacturing PreCheck Pilot — the Supply Chain Acceleration Markets Are Underpricing
Jun 30, 2026
Yen Hits 40-Year Low vs. Dollar — Intervention Risk Puts Carry Trades on a Hair Trigger
Jun 30, 2026
Luxshare Eyes $3.1B Hong Kong Raise — Apple's Rising Assembler Signals a Major Capacity Bet
Jun 30, 2026
U.S.-China Tech Race Moves to Third Markets — Government Policy Is the Hidden Competitive Lever
Jun 30, 2026
ACCC Sues Amazon Over Prime's AU$2.99 Ad Opt-Out Fee — a Contract Model Global Regulators Are Watching
Jun 30, 2026
Supreme Court Overturns 90-Year FTC Shield — Big Tech Antitrust Exposure Repriced
Jun 30, 2026
China June PMI Beat Was an AI Demand Signal — Not a Generic Trade Recovery
Jun 30, 2026
Tesla's Best Day in Over a Year Driven by Self-Driving Update, Not Deliveries
Jun 30, 2026BBIO — frequently asked
What is the BBIO stock price today?
The live BridgeBio Pharma (BBIO) price and an interactive chart are shown at the top of this page, updated in real time during US market hours (9:30 AM – 4:00 PM ET) and at the last close otherwise.
Where is BBIO listed?
BridgeBio Pharma (BBIO) is a US-listed equity traded on the NASDAQ / NYSE. It belongs to the 바이오 sector.
Is the latest BBIO news bullish or bearish?
We are not tracking BBIO news right now. New stories will appear in the news section below as they are published.
Prices are delayed outside US market hours and provided for information only — not investment advice. BridgeBio Pharma (BBIO) news is produced from public information.